Trina Storage launches the All-New Elementa with 25% more cycles at Intersolar Europe 2022It introduces the Next-Gen BESS solution that cuts Total Cost of Ownership (TCO) by 25% MUNICH, May ...
ANN ARBOR, Mich., May 06, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics and cell and molecular research for ...
Interactive Experience Designed to Showcase the 136,000sf cGMP Facility Located in Newark, CaliforniaCell Forge 1 is Operational in Preparation for the Company’s First Pivotal Trial with ALLO-501A for the Treatment ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based ...
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas MOUNTAIN VIEW, Calif., April 11, ...
Preclinical data demonstrate that edited iNK cells result in increased persistence, enhanced anti-tumor activity and extended survival supporting continued development as a novel therapeutic approach for solid tumors In vivo ...
SEATTLE, April 08, 2022 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an oncology company leveraging its proprietary integrated technologies to create next-generation off-the-shelf in vivo (VivoVec) and induced pluripotent stem cell ...
ARNSTADT, Germany, April 6, 2022 /PRNewswire/ -- On April 4, Contemporary Amperex Technology Thuringia GmbH (CATT), CATL's first plant outside of China, received the 2nd partial approval for the commissioning ...
Pune, India, April 02, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East ...
– SKYSCRAPER-02, the first randomized study of tiragolumab in extensive-stage small cell lung cancer (ES-SCLC), did not meet its co-primary endpoint of progression-free survival – – ES-SCLC is a hard-to-treat ...
Copyright © 2015 - 2021 Lifecarenews.in
